Although a matter of ongoing controversy, a mutation in CCR5 was reported to be associated with a lower risk of metastasis in breast cancer [12], and CCR5 expression in other cancers has been linked to recurrence risk and prognosis [13]. Here, CCR5 is linked to breast cancer.